{"altmetric_id":12214578,"counts":{"readers":{"mendeley":0,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["pristinepeak"],"posts_count":1}},"selected_quotes":["53: Acute and Late Toxicity in High-Risk Prostate Cancer Patients Treated with Androgen Suppression and\u2026"],"citation":{"altmetric_jid":"4f6fa5133cf058f610003423","authors":["Sergio Faria","Mariana Petrucelli","Fabio Cury","Marie Duclos","Luis Souhami"],"doi":"10.1016\/s0167-8140(16)33452-1","first_seen_on":"2016-09-26T07:39:58+00:00","issns":["01678140"],"journal":"Radiotherapy & Oncology","last_mentioned_on":1474874261,"links":["http:\/\/www.thegreenjournal.com\/article\/S0167-8140(16)33452-1\/fulltext?rss=yes&utm_source=dlvr.it&utm_medium=twitter"],"pubdate":"2016-09-01T00:00:00+00:00","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"},{"name":"Other Physical Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"S21","title":"53: Acute and Late Toxicity in High-Risk Prostate Cancer Patients Treated with Androgen Suppression and Hypofractionated Radiotherapy (Hyport) to the Prostate and Pelvic Nodes","type":"article","volume":"120","mendeley_url":"http:\/\/www.mendeley.com\/research\/53-acute-late-toxicity-highrisk-prostate-cancer-patients-treated-androgen-suppression-hypofractionat"},"altmetric_score":{"score":0.25,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.25},"context_for_score":{"all":{"total_number_of_other_articles":8435952,"mean":7.094002543155,"rank":7289318,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":8435952,"percentile":1},"similar_age_3m":{"total_number_of_other_articles":252954,"mean":12.697202270777,"rank":207749,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":252954,"percentile":1},"this_journal":{"total_number_of_other_articles":2186,"mean":2.2195725400458,"rank":1704,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":2186,"percentile":1},"similar_age_this_journal_3m":{"total_number_of_other_articles":260,"mean":0.98146718146718,"rank":120,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":260,"percentile":1}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":[],"by_discipline":[]}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/pristinepeak\/statuses\/780305323294720000","license":"gnip","citation_ids":[12214578],"posted_on":"2016-09-26T07:17:41+00:00","author":{"name":"Pristine Peak","image":"https:\/\/pbs.twimg.com\/profile_images\/1203819152\/miniature-rose-1_normal.jpg","description":"Radoncologist by profession. Passionate about Proton Therapy! Moderator @isocentre. Technofreak and psycho-babblist!","id_on_source":"pristinepeak","tweeter_id":"232776719","geo":{"lt":null,"ln":null},"followers":248},"tweet_id":"780305323294720000"}]}}